Breaking News
October 18, 2018 - 5 Strength-Training Mistakes to Avoid
October 18, 2018 - Immune system’s balancing act keeps bowel disease in check
October 18, 2018 - Anti-inflammatory drug effective for treating lymphedema symptoms | News Center
October 18, 2018 - Keeping Your Voice Young
October 18, 2018 - One-time universal screening recommended to tackle increase in hepatitis C
October 18, 2018 - Researchers to develop new stem cell-based strategies for treating vision disorders
October 18, 2018 - Detecting epigenetic signature may help people stay ahead of inflammatory bowel disease
October 18, 2018 - Understanding AFib: Slowing down the dancing heart
October 18, 2018 - Using NMR to Reduce Fraud
October 18, 2018 - New automated model identifies dense breast tissue in mammograms
October 18, 2018 - Mysterious polio-like illness baffles medical experts while frightening parents
October 18, 2018 - Cases of Acute Flaccid Myelitis on the rise across U.S.
October 18, 2018 - Dietary fiber reduces brain inflammation during aging
October 18, 2018 - New tool could help prioritize recovery efforts for the poorest hit by natural disasters
October 18, 2018 - Hundreds of dietary supplements shown to contain unapproved drugs
October 18, 2018 - Active Pharmaceuticals ID’d in >700 Dietary Supplements
October 18, 2018 - Cell death protein also damps inflammation
October 18, 2018 - Health Highlights: Oct. 15, 2018
October 18, 2018 - Largest study of ‘post-treatment controllers’ reveals clues about HIV remission
October 18, 2018 - Bad Blood in Silicon Valley: A conversation with John Carreyrou
October 18, 2018 - ANTRUK’s Annual Lecture sends out message on shortage of funds for antibiotic research
October 18, 2018 - NAM special publication outlines steps to ensure interoperability of health care systems
October 18, 2018 - Novel method uses just a drop of blood to monitor effect of lung cancer therapy
October 18, 2018 - New blood test could spare cancer patients from unnecessary chemotherapy
October 18, 2018 - Training young researchers to work with data volumes arising in the health sector
October 18, 2018 - New Metrohm IC method is reliable and convenient to use for zinc oxide assay
October 18, 2018 - Global AIDS, TB fight needs more money: health fund
October 18, 2018 - Understanding the forces that cause sports concussions
October 18, 2018 - Research points to new target for treating periodontitis
October 18, 2018 - New tool improves assessment of postpartum depression symptoms
October 18, 2018 - From Biopsy to Diagnosis
October 18, 2018 - Sexual harassment and assault linked to worse physical/mental health among midlife women
October 18, 2018 - Stumped by medical school? A Q&A with a learning specialist
October 18, 2018 - Report predicts life expectancy in 2040, Spain comes out on top
October 18, 2018 - Self-lubricating condoms may help raise condom usage
October 18, 2018 - Targeting immune checkpoints in microglia could reduce out-of-control neuroinflammation
October 18, 2018 - Study finds changes in antiepileptic drug metabolism during different trimesters of pregnancy
October 18, 2018 - Autonomic nervous system directly controls stem cell proliferation, study shows
October 18, 2018 - FDA Approves Talzenna (talazoparib) for gBRCAm HER2-Negative Locally Advanced or Metastatic Breast Cancer
October 18, 2018 - Sleeping Beauty technique helps identify genes responsible for NAFLD-associated liver cancer
October 18, 2018 - Many U.S. adults confused about primary care, study shows
October 18, 2018 - UC researcher focuses on light-mediated therapies to target breast cancer
October 18, 2018 - With philanthropic gifts, Stanford poised to make major advances in neurosciences | News Center
October 18, 2018 - Mice study shows antibiotics are not always necessary to cure sepsis
October 18, 2018 - Researchers discover why heart contractions are weaker in individuals with HCM
October 18, 2018 - Participation in organized sport during childhood may have long-term skeletal benefits
October 18, 2018 - Probiotic/antibiotic combination could eradicate drug-resistant bacteria
October 17, 2018 - More Socioeconomic Challenges for Hispanic Women With HIV
October 17, 2018 - 49,XXXXY syndrome – Genetics Home Reference
October 17, 2018 - Scientists uncover possible new causes of Tourette syndrome
October 17, 2018 - Girl undergoes unusual heart surgery after compassionate-use exemption | News Center
October 17, 2018 - Health Issues That Are Sometimes Mistaken for Gluten Sensitivity
October 17, 2018 - Elective induction of labor at 39 weeks may be beneficial option for women and their babies
October 17, 2018 - New smart watch algorithms can accurately monitor wearers’ sleep patterns
October 17, 2018 - Researchers demonstrate epigenetic memory transmission via sperm
October 17, 2018 - FDA, DHS announce memorandum of agreement to address cybersecurity in medical devices
October 17, 2018 - Health Tip: Know the Risks of Chicken Pox
October 17, 2018 - Immunotherapy effective against hereditary melanoma
October 17, 2018 - Researchers reveal new mechanism for how animal cells stay intact | News Center
October 17, 2018 - Alzheimer's Goes Under the Cryo-Electron Microscope
October 17, 2018 - Medicare for all? CMS chief warns program has enough problems already
October 17, 2018 - Metrohm Raman introduces Mira P handheld Raman system
October 17, 2018 - Expanding the knowledge about hippocampus to better understand cognitive deficits in MS
October 17, 2018 - Study of Nigerian breast cancer patients reveals prevalence of aggressive molecular features
October 17, 2018 - Many healthy children may have metabolic risk factors, finds study
October 17, 2018 - A new antibiotic could be a better, faster treatment for tuberculosis
October 17, 2018 - “I will not become a Robot Doctor”: A medical student vows to practice compassion
October 17, 2018 - Study findings may explain sporadic outbreaks of C. difficile infections in hospitals
October 17, 2018 - Purdue researchers develop new chemical process to find better drug ‘fits’ for patients
October 17, 2018 - Yale researchers develop way to attack RNA with small-molecule drugs
October 17, 2018 - New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug
October 17, 2018 - Alnylam Announces Plan to Initiate Rolling Submission of a New Drug Application and Pursue Full Approval for Givosiran
October 17, 2018 - Nine cases of polio-like illness suspected in children in illinois
October 17, 2018 - Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries
October 17, 2018 - Patients once thought incurable can benefit from high-dose radiation therapy
October 17, 2018 - Researchers awarded grant to advance testing of experimental heroin vaccine
October 17, 2018 - Researchers examine SSRI use during pregnancy and major gestational malformations
October 17, 2018 - FDA grants Rare Pediatric Disease Designation for Immusoft’s Iduronicrin genleukocel-T
October 17, 2018 - Reliable Respiratory announces acquisition of Attleboro Area Medical Equipment
October 17, 2018 - Study reveals link between childhood abuse and higher arthritis risk in adulthood
Financial savings lower than anticipated for generic oral chemotherapy

Financial savings lower than anticipated for generic oral chemotherapy

image_pdfDownload PDFimage_print

A find out about by means of researchers on the College of North Carolina Eshelman College of Pharmacy and Lineberger Complete Most cancers Heart made up our minds the associated fee financial savings for a generic model of an orally administered most cancers remedy have been lower than anticipated—a discovering that questions the affect generic medicine may have on controlling well being care prices.

The researchers record within the JAMA Inner Medication that the associated fee for one fill of the generic type of the chemotherapy remedy capecitabine used to be $2,328 remaining yr. That value used to be 36 % not up to the projected branded drug value in 2016—a financial savings the researchers deemed modest in comparison to discounts observed for different generic medicine.

“For this oral most cancers remedy, we do not see the extent of value relief that we might be expecting for generic drug access,” mentioned the find out about’s senior creator Stacie Dusetzina, PhD, a UNC Lineberger member and assistant professor within the UNC Eshelman College of Pharmacy.

Dusetzina mentioned pageant from generic medicine has been a very powerful instrument for curtailing clinical prices and increasing remedy get right of entry to. On the identical time, corporations would possibly use generic value discounts as a rationale for environment upper costs for brand-name medicine, with the justification that costs can be considerably decrease after generics input the marketplace.

Capecitabine used to be one of the most first high-priced, orally administered most cancers remedies to lose patent coverage in the USA, the researchers record. They discovered that will increase in the cost of the brand-name drug, and a smaller-than-expected relief in the cost of the generic variations of the remedy, reduced the affect of generic pageant on costs 3 years after the brand-name drug got here off patent.

“The usage of capecitabine as a case find out about for the possible impact of generic pageant for orally-administered anti-cancer remedies, we discovered that discounts within the listing value have been extra modest than the ones noticed for different medicine with the similar collection of generic marketplace competition,” mentioned the find out about’s first creator Ashley Cole, MPH, a doctoral pupil and graduate analysis assistant within the UNC Eshelman College of Pharmacy.

The researchers used industrial insurance coverage claims information to estimate prescription costs for branded and generic capecitabine between 2002 and 2016. Capecitabine misplaced patent coverage in 2013, and in step with the researchers’ information, the primary fill for the generic selection used to be in March of 2014. The cost of a typical one-month provide of generic capecitabine averaged $2,598 in 2014, best 17 % under the projected branded drug value. By means of 2016, the typical generic value dropped to $2,328, which used to be 36 % under the projected branded drug value. Different research have discovered better financial savings for generic access, even in settings with a identical collection of competition.

In addition they made up our minds that brand-name drug costs larger over the years, and generic costs adopted go well with. In 2016, the cost of the generic capecitabine used to be very similar to the listing value of the brand-name drug in 2010, and it used to be 70 % upper than the brand-name drug’s listing value in 2002.

“The cost of capecitabine has greater than doubled since 2002, so even after generic access, the fee paid by means of well being plans continues to be upper than the branded drug’s authentic listing value after you alter for inflation,” Dusetzina mentioned. “If costs after generic access are in the end upper than authentic listing costs, then it’s not transparent that sufferers could have more uncomplicated get right of entry to to remedy following generic access.”

On this find out about of commercially insured sufferers, maximum sufferers had decrease out-of-pocket prices after generic access. On the other hand, about 10 % of folks paid greater than $100 for one fill of the drugs.

“As we see extra sufferers enrolled in excessive deductible well being plans, paying deductibles or co-insurance for his or her medicine, this loss of value relief would possibly without delay affect sufferers,” Dusetzina mentioned.

The findings will have coverage implications. Encouraging tough generic pageant may assist keep an eye on well being care prices, Dusetzina mentioned, because the collection of producers providing generic merchandise has been discovered to be similar to worth discounts.

“There may be an ongoing nationwide dialog round prescription drug costs, specifically forte medicine, like the ones utilized in oncology,” Cole mentioned. “Some have prompt that generic price cutting war can be a market-based option to this drawback. Our find out about supplies early proof that generic pageant by myself is probably not sufficient to rein within the excessive costs for orally administered most cancers remedies.”


Discover additional:
FDA takes steps to spice up generic pageant, prohibit costs

Magazine reference:
JAMA Inner Medication

Equipped by means of:
UNC Lineberger Complete Most cancers Heart

Tagged with:

About author

Related Articles